AAAna Kélvia Araújo Arcanjo

Ana Kélvia Araújo Arcanjo

*This is an algorithmically generated author record based on publicly available information.

Ana Kélvia Araújo Arcanjo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • NÍVEIS DE HEMOGLOBINA NA ANEMIA FALCIFORME: ASSOCIAÇÕES COM MARCADORES LABORATORIAIS, EXPOSIÇÃO TRANSFUSIONAL E DISTÂNCIA AO HEMOCENTRO

    by Ana Kélvia Araújo Arcanjo, Francisco Kauê Carvalho Aguiar, Ivina Rhaissy Ximenes de Mesquita, Vicente de Paulo Teixeira Pinto, João Batista Cajazeiras, Romélia Pinheiro Gonçalves Lemes, Maria Gleiciane de Queiroz Martins, Kainner Waldembergson Fonteles Teixeira, Dino César da Silva Clemente, José Jackson Do Nascimento Costa

    A doença falciforme é uma hemoglobinopatia hereditária de alta relevância em saúde pública. A anemia hemolítica crônica, os episódios de vaso-oclusão e as complicações multissistêmicas representam desafios no manejo clínico. Este estudo objetivou investigar determinantes clínico-laboratoriais e contextuais dos níveis de hemoglobina em pacientes com doença falciforme, com foco nas diferenças por sexo, nas associações com biomarcadores e na influência da distância ao hemocentro. Trata-se de um estudo transversal com 50 pacientes adultos acompanhados em um hemocentro regional. Foram analisadas variáveis hematimétricas, bioquímicas, frações de hemoglobina, LDH, ferritina, reticulócitos e a distância ao hemocentro. O projeto foi aprovado pelo Comitê de Ética em Pesquisa, sob o parecer nº 6.832.101. A análise de regressão linear múltipla explicou 24,1% da variação da hemoglobina, com associação positiva da HbF e dos reticulócitos e associação negativa do LDH. A HbF foi o marcador mais acurado para predizer Hb >10 g/dL (AUC 77,0%). A distância ao hemocentro mostrou impacto mais acentuado sobre a hemoglobina em mulheres (declínio de 0,005 g/dL por km), em comparação com homens (0,002 g/dL). Os achados demonstram que os níveis de hemoglobina são modulados por fatores clínico-laboratoriais e contextuais, como o papel protetor da HbF, a hemólise e as desigualdades de gênero no acesso ao cuidado. O estudo sustenta a importância de políticas públicas que reduzam essas desigualdades e integrem biomarcadores laboratoriais aos determinantes sociais de saúde para um manejo mais eficaz.

  • Open Access

    Use of educational manuals on blood components in hemotherapy and hematology services in Brazil: a scoping review

    by Fernando Nogueira Cavalcante, Ana Kélvia Araújo Arcanjo Arcanjo, Antonio Neudimar Bastos Costa Costa, Iago Parente Ferreira Gomes Gomes, Joyce Carneiro Albuquerque Albuquerque, Lidia Andrade Lourinho Lourinho

    Hemotherapy has as its principle the rational use of blood, consisting of the appropriate use of blood components such as red blood cells, platelets, plasma and cryoprecipitate, obtained from the donation of whole blood. The use of educational manuals stands out as support in this process, which helps in the organization and safety of transfusion practice. The objective of the study was to map educational manuals on blood components in hemotherapy and hematology services in Brazil. This is a scoping review based on the recommendations of the Joanna Briggs Institute (JBI) and structured based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoing Reviews (PRISMA-ScR) checklist and was registered in the Open Science Framework, under DOI: 10.17605/OSF.IO/642JZ. The publications had a predominance of articles in Portuguese language 100%. There was a prevalence of studies with a descriptive approach 80%, action research 10% and randomized studies 10%, as well as publications carried out in Brazil 100%. The study showed us the importance of manuals and the difference caused by their use in terms of standardization in Brazilian health units.

  • Open Access

    Impact of temporary and involuntary suppression of hydroxyurea treatment on hematological and clinical parameters in patients with sickle cell disease

    by Ana Kélvia Araújo Arcanjo, Eric Arcanjo Bringel, José Jackson Do Nascimento Costa, Alaíde Maria Rodrigues Pinheiro, Antônia Moemia Lúcia Rodrigues Portela, Júlia Oliveria de Assis, Vicente de Paulo Teixeira Pinto

    Objective: Here we investigate the impact of involuntary and temporary interruption of hydroxyurea (HU) treatment in patients with Sickle Cell Disease (SCD). Methods: Clinical and hematological parameters were explored in 30 patients with SCD under treatment with HU. The study was performed in two different periods: 1 - During nine months of involuntary discontinuation (April/2015 to January/2016) and 2 – During nine months after resumption of the treatment (March/2016 to December/2016). Results: The resumption of HU treatment improved the hematological parameters, by increasing levels of hemoglobin (+0.65±0.71), hematocrit (+1.16±2.26), mean corpuscular volume (+8.33±5.89), mean corpuscular hemoglobin (+3.15±2.65). There was a reduction in red blood cell distribution width (-0.66±1.69), reticulocytes (-2.53±1.96), leukocytes (-1122±2764) and platelets numbers (-79.933±162.756). These was followed by a reduction in hospital admissions (-0.30±0.79) and in the number of pain episodes (-0.97±1.19), whereas the denial in episodes of pain crisis increased (+1.43±1.43). After resumption, in period 2, hemoglobin levels were inversely correlated with blood transfusion numbers (p=0.034) and acute thoracic syndrome (p=0.017). The hematocrit was inversely correlated with the number of consultations (p=0.030) and the number of times patients denied crisis (p=0.002). Conclusions: Our study shows that the treatment with HU improves clinical and haematological parameters in patients and highlights the negative effects of the discontinuation of the treatment in the quality of life in patients with SCD.